ArticleCancer biology & therapy2022

Repeated treatments of Capan-1 cells with PARP1 and Chk1 inhibitors promote drug resistance, migration and invasion.

Ne Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.